Brainstorm Cell Therapeutics reported 0 in Sales Revenues for its fiscal quarter ending in March of 2025.





Sales Change Date
Alterity Therapeutics Limited AUD 596.04K 584.66K Dec/2025
Biogen USD 2.74B 490M Jun/2026
Brainstorm Cell Therapeutics 0 0 Mar/2025
Cipla INR 71.19B 5.78B Jun/2026
Clal Biotechnology ILS 3.41M 2M Dec/2022
Compugen USD 6.35M 60.98M Mar/2026
CSL USD 8.33B 4.79B Dec/2025
Cytokinetics USD 28.6M 9.25M Jun/2026
Gilead Sciences USD 7.8B 800M Jun/2026
Grifols EUR 2B 306.7M Mar/2026
Halozyme Therapeutics USD 481M 104M Jun/2026
Mesoblast USD 30.3M 0 Jun/2026